Sunshine Biopharma, Inc.
NCM: SBFMLive Quote
📈 ZcoreAI Score
Our AI model analyzes Sunshine Biopharma, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get SBFM Z-Score →About Sunshine Biopharma, Inc.
Healthcare
Drug Manufacturers - Specialty & Generic
Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
📊 Fundamental Analysis
Sunshine Biopharma, Inc. demonstrates a profit margin of -16.5%, which is below the sector average, suggesting competitive pressure.
The company recently reported -10.6% revenue growth, which is negative, indicating a recent decline in revenue.
Return on Equity (ROE) is -25.7%, which indicates that capital utilization is currently under pressure.
At a current price of $1.00, SBFM currently trades near the bottom of its 52-week range (3%), indicating potential value or weakness (Range: $0.95 - $2.43).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$4.90M
Trailing P/E
--
Forward P/E
0.00
Beta (5Y)
1.60
52W High
$2.43
52W Low
$0.95
Avg Volume
38K
Day High
Day Low